Mongaya, Rio D.

HRN: 21-16-82  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/17/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/17/2024
01/24/2024
IV
200mg
Q8H
T/c Fournier’s Gangrene; Infected Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: